NEA Management Company as of Sept. 30, 2020
Portfolio Holdings for NEA Management Company
NEA Management Company holds 54 positions in its portfolio as reported in the September 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Sprout Social Com Cl A (SPT) | 9.1 | $215M | 5.6M | 38.50 | |
| Allakos (ALLK) | 7.8 | $185M | 2.3M | 81.45 | |
| Adaptimmune Therapeutics Adr (ADAP) | 5.8 | $136M | 17M | 7.98 | |
| Crispr Therapeutics Namen Akt (CRSP) | 5.6 | $133M | 1.6M | 83.64 | |
| Oyster Point Pharma | 5.3 | $125M | 5.9M | 21.11 | |
| Mersana Therapeutics (MRSN) | 4.7 | $111M | 6.0M | 18.62 | |
| Rhythm Pharmaceuticals (RYTM) | 4.5 | $107M | 4.9M | 21.67 | |
| Black Diamond Therapeutics (BDTX) | 4.4 | $104M | 3.4M | 30.23 | |
| Akouos | 4.2 | $98M | 4.3M | 22.87 | |
| Nkarta (NKTX) | 3.7 | $87M | 2.9M | 30.06 | |
| Imara | 3.5 | $82M | 4.0M | 20.34 | |
| Trillium Therapeutics Com New | 3.5 | $82M | 5.7M | 14.21 | |
| Mirum Pharmaceuticals (MIRM) | 3.4 | $81M | 4.2M | 19.27 | |
| Aurinia Pharmaceuticals (AUPH) | 3.2 | $76M | 5.2M | 14.73 | |
| Annexon (ANNX) | 3.2 | $76M | 2.5M | 30.23 | |
| Ardelyx (ARDX) | 3.0 | $72M | 14M | 5.25 | |
| Inozyme Pharma (INZY) | 2.7 | $64M | 2.4M | 26.29 | |
| Casper Sleep | 1.9 | $45M | 6.2M | 7.19 | |
| Galera Therapeutics (GRTX) | 1.7 | $39M | 4.4M | 9.04 | |
| Verona Pharma Ads (VRNA) | 1.3 | $32M | 5.1M | 6.24 | |
| Metacrine Ord | 1.3 | $31M | 3.1M | 10.21 | |
| Glycomimetics (GLYC) | 1.2 | $28M | 9.1M | 3.07 | |
| Mei Pharma Com New | 1.1 | $27M | 8.5M | 3.12 | |
| Bloom Energy Corp Com Cl A (BE) | 1.0 | $24M | 1.3M | 17.97 | |
| Trevi Therapeutics (TRVI) | 1.0 | $24M | 5.9M | 4.03 | |
| Genocea Biosciences (GNCAQ) | 1.0 | $24M | 10M | 2.29 | |
| Aveo Pharmaceuticals | 1.0 | $24M | 4.0M | 5.94 | |
| Geron Corporation (GERN) | 1.0 | $23M | 14M | 1.74 | |
| Phasebio Pharmaceuticals (PHASQ) | 1.0 | $23M | 6.6M | 3.51 | |
| Affimed Therapeutics B V | 0.9 | $21M | 6.1M | 3.39 | |
| Champions Oncology Com New (CSBR) | 0.7 | $16M | 1.7M | 9.25 | |
| Cti Biopharma Corp Com New | 0.7 | $15M | 7.1M | 2.15 | |
| Inventiva Sa Ads (IVA) | 0.5 | $12M | 1.0M | 11.82 | |
| Liquidia Technologies (LQDA) | 0.5 | $12M | 2.5M | 4.92 | |
| Trevena | 0.5 | $11M | 3.8M | 2.99 | |
| Obseva Sa | 0.5 | $11M | 4.6M | 2.48 | |
| Cloudflare Cl A Com (NET) | 0.5 | $11M | 2.8M | 4.11 | |
| Xenon Pharmaceuticals (XENE) | 0.5 | $11M | 992k | 11.07 | |
| DZS (DZSI) | 0.4 | $9.0M | 956k | 9.37 | |
| Strongbridge Biopharma Shs Usd | 0.4 | $8.7M | 4.1M | 2.10 | |
| Synlogic | 0.4 | $8.5M | 4.2M | 2.02 | |
| Marker Therapeutics Ord | 0.3 | $7.5M | 5.0M | 1.50 | |
| Lumos Pharma (LUMO) | 0.3 | $7.3M | 527k | 13.82 | |
| Senseonics Hldgs (SENS) | 0.2 | $5.5M | 14M | 0.39 | |
| Erytech Pharma Sa Adr | 0.2 | $3.8M | 625k | 6.00 | |
| Lexicon Pharmaceuticals Com New (LXRX) | 0.1 | $3.4M | 2.4M | 1.44 | |
| Millendo Therapeutics | 0.1 | $2.9M | 1.8M | 1.63 | |
| Tracon Pharmaceuticals (TCON) | 0.1 | $1.8M | 347k | 5.17 | |
| Draftkings Com Cl A | 0.1 | $1.4M | 24k | 58.82 | |
| Regulus Therapeutics Com New | 0.0 | $1.1M | 2.1M | 0.51 | |
| Akari Therapeutics Adr | 0.0 | $787k | 452k | 1.74 | |
| Palantir Technologies Cl A (PLTR) | 0.0 | $712k | 75k | 9.50 | |
| Altair Engr Com Cl A (ALTR) | 0.0 | $503k | 12k | 42.00 | |
| Sunesis Pharmaceuticals Com Par | 0.0 | $162k | 130k | 1.25 |
